发明名称 New arylacetic acid N-phenylamide or arylcarboxylic acid N-benzylamide derivatives, used as antithrombotic agents in treatment of e.g. deep leg vein thrombosis, are Factor Xa and thrombin inhibitors
摘要 Amidino- or cyano-substituted arylacetic acid N-phenylamide or arylcarboxylic acid N-benzylamide derivatives (I) are new. Amidino- or cyano-substituted arylacetic acid N-phenylamide or arylcarboxylic acid N-benzylamide derivatives of formula (I) and their isomers and salts are new. m = 0 and; n = 1; or m = 1; and n = 0; Ar' = phenylene or naphthylene (both optionally substituted (os) by F, Cl, Br, CF3, T', OH, OT', phenyl-(1-3C)alkoxy, NH2, NHT' or NT'2, phenyl being further os by F, Cl, Br or T), or thienylene, thiazolylene, pyridinylene, pyrimidinylene, pyrazinylene or pyridazinylene (all os on C by T'); T' = 1-3C alkyl; R1 = T' (os by NH2, NHT', NT'2, phenyl, naphthyl, heteroaryl or 4-7 membered cycloalkyleneimino), 3-7C cycloalkyl substituted in the 1-position by 5-7 membered cycloalkyleneiminocarbonyl, NH2, 1-5C alkylamino, 5-7C cycloalkylamino or phenyl-(1-3C) alkylamino (all os on N by benzoyl or phenylsulfonyl or by T' or COT' (both os by COOH), 4-7 membered cycloalkyleneiminocarbonyl or cycloalkyleneiminosulfonyl (both os by T), phenyl (os by F, Cl, Br, CF3, SO2NH2, T' or OT'; and further os by F, Cl, Br, CF3, T' or OT'), OT', phenyl-(1-3C) alkoxy, heteroaryloxy or heteroaryloxy-(1-3C) alkoxy (all os in the 2- or 3-position of the alkoxy moiety by NH2, NHT' or NT'2) or 3-7C cycloalkoxy (optionally having CH2 in the 2- or 3-position replaced by NH or NQ); Q = T' (os in the 2- or 3-position by NH2, NHT' or NT'2), COT', arylcarbonyl, arylsulfonyl, CONH2, CONHT', CONT'2, C(=NH)NH2, C(=NH)NHT' or C(=NH)NT'2; R2 = H, F, Cl, Br, T', OH or OT'; R3 = H or T'; R4 = H or T' (os by COOH); R5 = CN or amidino (os by 1 or 2 T'); and heteroaryl = 5-membered heteroaryl (os by T' and containing NH, NT', O or S, NH or NT' plus O, S or N, NH or NT' plus two N or O or S plus two N) or 6-membered heteroaryl (os by T and containing 1 or 2 N) COOH moieties may be replaced by groups convertible into COOH in vivo or groups which are negatively charged under physiological conditions; amino or imino moieties are os by in vivo cleavable groups. An Independent claim is included for the preparation of (I).
申请公布号 DE10025663(A1) 申请公布日期 2001.11.29
申请号 DE20001025663 申请日期 2000.05.24
申请人 BOEHRINGER INGELHEIM PHARMA KG 发明人 RIES, UWE;PRIEPKE, HENNING;HECKEL, ARMIN;NAR, HERBERT;STASSEN, JEAN MARIE;WIENEN, WOLFGANG
分类号 C07C257/18;C07C311/21;C07C311/46;C07D295/135;C07D295/185;C07D295/192;(IPC1-7):C07D295/192;C07D207/12;C07D211/44;A61K31/40 主分类号 C07C257/18
代理机构 代理人
主权项
地址